arrow
E

Elisabetta Ferraro

University of Pisa
H指数:34
被引数:9,496

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hybrid PLGA nanoparticles outperform SLNs in intracellular delivery of an anti-inflammatory lipid mediator to skeletal muscle cells

聚乳酸-羟基乙酸共聚物(PLGA)杂化纳米粒子在抗炎脂质介质向骨骼肌细胞的细胞内递送方面优于固体脂质纳米粒(SLNs)

2026-09-010
OAAI
Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural Mesothelioma

开发一种靶向间皮素的工程化支架蛋白作为胸膜间皮瘤的诊疗剂

2025-10-270
OAAI
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty

真实世界中奥法鲁单抗治疗复发型多发性硬化24个月的效果:疗效、安全性及虚弱症的影响

2025-09-190
OAAI
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy

怀孕期间暴露于富马酸二甲酯的多发性硬化症妇女的意大利多中心队列的母婴结局

2024-09-120
PRE
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression

多发性硬化症患者的性功能障碍: 疾病严重程度,疾病感知和抑郁的作用

2023-03-134
OAAI
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

整个怀孕期间暴露于那他珠单抗: 在意大利多发性硬化症女性队列中的有效性和安全性

2022-09-3015
PRE
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register

向继发性进行性多发性硬化症临床过渡的有效定义: 来自意大利MS注册中心的一项研究

2022-08-157
PRE
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice
2022-01-1324
OAAI
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation
2021-02-1021
PREAI